Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.
In the high-stakes world of pharmaceuticals, effective marketing hinges on understanding diverse healthcare professionals' intricate needs and motivations. Generative AI, ushering in a new era of possibility with the advent of the persona bot, offers a transformative solution to activate segmentation studies by injecting a much-needed dose of dynamism.
Persona bots, fueled by sophisticated algorithms and trained on robust datasets, embody the attitudes, behaviours, and preferences of real-world doctors, patients, and pharmacists. By transforming static reports into dynamic and interactive tools, these AI-powered avatars enable marketers to engage in interactive ‘dialogues’, providing deeper understanding and real-time feedback. However, realising this potential requires careful planning, ethical considerations, and a commitment to continuous learning and adaptation.
In this article, we explore persona bots' existing and promising applications in healthcare market research, including virtual focus groups, streamlined message testing, and optimising omnichannel strategies. We're also analysing emerging trends in this field, including the potential of multimodal inputs and outputs and VR.
Ipsos’ new solution, Healthcare PersonaBot, is available now. Watch the video to see how Healthcare PersonaBot can unlock the full potential of your healthcare segmentation!
